Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients

por Limone, Brendan L, Sidovar, Matthew F, Coleman, Craig I
Publicado em 2013

Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort

por Sidovar, Matthew F, Limone, Brendan L, Coleman, Craig I
Publicado no Patient Relat Outcome Meas (2016)

Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Cost-Effectiveness Models

por Limone, Brendan L., Baker, William L., Kluger, Jeffrey, Coleman, Craig I.
Publicado em 2013

Mapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients

por Sidovar, Matthew F, Limone, Brendan L, Lee, Soyon, Coleman, Craig I
Publicado em 2013

Impact of angina frequency on health utility values of patients with chronic stable angina

por Kohn, Christine G, Parker, Matthew W, Limone, Brendan L, Coleman, Craig I
Publicado em 2014

The burden of cystic fibrosis in the Medicaid population

por Hassan, Mariam, Bonafede, Machaon M, Limone, Brendan L, Hodgkins, Paul, Sawicki, Gregory S
Publicado no Clinicoecon Outcomes Res (2018)

Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations

por Accortt, Neil A, Chung, James B, Bonafede, Machaon, Limone, Brendan L, Mannino, David M
Publicado no Int J Chron Obstruct Pulmon Dis (2017)

Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US

por Mearns, Elizabeth S, Liang, Michael, Limone, Brendan L, Gilligan, Adrienne M, Miller, Jeffrey D, Schaum, Kathleen D, Waycaster, Curtis R
Publicado no Clinicoecon Outcomes Res (2017)